The latest issue in the From Policy to Practice report series from The Gerontological Society of America (GSA) addresses recent labeling changes for OTC analgesics and highlights important considerations when recommending ...
Jul 17, 2018
0
3
A team of researchers has uncovered a specific gene variant associated with an adverse drug reaction resulting in liver injury in a people with multiple sclerosis (MS). It is the first time researchers have been able to establish ...
Jul 16, 2018
0
46
(HealthDay)—The first biosimilar drug to Neulasta has been approved by the U.S. Food and Drug Administration. Fulphila (pegfilgrastim) is approved for patients with non-myeloid cancer who are receiving myelosuppressive ...
Jun 6, 2018
0
0
(HealthDay)—Doptelet (avatrombopag) has been approved by the U.S. Food and Drug Administration to treat adults with chronic liver disease who are slated to have a medical or dental procedure.
May 21, 2018
0
13
The frequency of adverse reactions to benznidazole is high when treating chronic Chagas patients, although the effects were mostly mild, according to a study led by ISGlobal, in collaboration with the Hospital Clinic of Barcelona. ...
Feb 21, 2018
0
8
First results from the Personal Genome Project Canada, which sequenced the entire personal genomes of 56 healthy participants, suggest whole genome sequencing can benefit health care in Canada, according to results published ...
Feb 5, 2018
0
4
A study led by researchers at RCSI (Royal College of Surgeons in Ireland) has identified a new genetic test that can be used to predict if a patient with epilepsy will develop an adverse reaction to a common anti-epileptic ...
Jan 26, 2018
0
26
An analysis of published studies and reports indicates that a number of herbal products may affect the properties of prescription drugs, leading to alterations in the drugs' effectiveness as well as potentially dangerous ...
Jan 24, 2018
0
36
Those with Chronic Obstructive Pulmonary Disease (COPD), together with other chronic illnesses, are at greater risk of adverse medication reactions, according to a new study.
Jan 15, 2018
0
10
(HealthDay)—Ozempic (semaglutide) has been approved by the U.S. Food and Drug Administration as a weekly injection to treat type 2 diabetes in adults.
Dec 6, 2017
0
4
